A recent study reveals that individuals who come off popular slimming jabs like semaglutide or tirzepatide tend to recover reduced body mass far faster than those who stop traditional diet and exercise plans.
Published data in a prominent health publication demonstrates that while obese people can lose about a fifth of their body weight while using the jabs, the weight is regained at an estimated rate of nearly a kilo each month once they quit.
"People using these treatments should be aware of the risk of quick weight regain when the therapy concludes," cautioned researcher Dr. Susan Jebb.
Such speed of recovery means a return to pre-treatment weight within about 18 months.
Weighing Approaches
The study, which reviewed dozens of trials involving over 9,000 of participants, contrasted the outcomes of these new drugs with older methods.
The team point out that individuals who shed pounds through dieting generally have a less rapid creep back—perhaps 100 grams monthly—once they finish.
The Reason for the Fast Regain
Doctors suggest the mode of action of the jabs accounts for the accelerated regain.
The injections imitate a natural hormone called GLP-1, which controls feelings of fullness.
"Long-term administration of GLP-1 concentrations far above than normal might result in the body to generate a reduced amount of its own natural hormone, and may also diminish responsiveness to its actions," explained Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this GLP-1 'fix' results in hunger is no longer kept in check, making binge eating a significant risk."
An Ongoing Issue?
Health authorities advise the jabs for individuals with weight-linked medical conditions, accompanied by recommended lifestyle changes.
Professionals contend that, considering the significant potential of relapse, the treatment should be considered long-term.
This view is echoed by pharmaceutical companies, who say that the results "emphasize the long-term character of obesity," comparing it to managing diseases like diabetes.
User Testimonies
Users who have discontinued the jabs report a sudden return of appetite.
"I experienced a switch flipping and I was suddenly starving," recalled one woman.
This difficulty is worsened if individuals have not established permanent lifestyle or habit modifications during therapy.
Significant Adoption
Survey data indicate that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with demand being substantial.
- Use is higher among females than males.
- The middle-aged age group shows the greatest level of interest.
- Many obtain the medications through private healthcare rather than public health services.
In conclusion, researchers emphasize that while these medications are powerful tools for shedding pounds, they are not a magic cure and long-term success likely depends on ongoing lifestyle support.
